Medicare Enrolled
Dr. Michael Dourmashkin, M.D.
Urology Physician · Melville, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dourmashkin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dourmashkin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dourmashkin
Dr. Michael Dourmashkin is an urology physician in Melville, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dourmashkin performed 6,497 Medicare services across 3,488 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dourmashkin received a total of $4,813 from 49 pharmaceutical and/or device companies across 237 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dourmashkin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in NY
$4,813 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,497
Medicare services
Top 14% in NY for urology physician
3,488
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~325 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,378 | $3 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,133 | $75 | $313 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,115 | $10 | $48 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
803 | $8 | $9 |
| PSA test (prostate cancer screening) | 448 | $18 | $55 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
107 | $12 | $177 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
105 | $229 | $965 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
102 | $51 | $210 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
102 | $8 | $24 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
101 | $8 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
97 | $13 | $49 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
96 | $58 | $220 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
89 | $86 | $394 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
87 | $18 | $55 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
84 | $8 | $26 |
| Injection, amikacin sulfate, 100 mg | 82 | $1 | $17 |
| Catheter specimen collection A procedure to collect a specimen using a catheter. This service is available in all places of service. |
75 | $8 | $9 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $50 | $198 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $114 | $441 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
54 | $74 | $590 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
50 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
50 | $8 | $24 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
48 | $25 | $77 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
48 | $47 | $172 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
37 | $32 | $121 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
27 | $10 | $32 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $122 | $446 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
16 | $80 | $290 |
| Antimicrobial drug detection test A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample. |
14 | $5 | $14 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
22.1% medium
76.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,813
Total received (2018-2024)
Avg $688/year across 7 years
Top 33% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
237
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,488 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$325 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$338
2023
$717
2022
$474
2021
$207
2020
$401
2019
$1,066
2018
$1,610
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$92
ABBVIE INC.
$72
Endo Pharmaceuticals Inc.
$45
Janssen Biotech, Inc.
$41
ABC Home Medical Supply, Inc.
$39
Verity Pharmaceuticals Inc.
$20
Laborie Medical Technologies Corp.
$15
Axonics, Inc.
$14
Top 3 companies account for 61.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$562
Astellas Pharma US Inc
$457
Coloplast Corp
$365
Sumitomo Pharma America, Inc.
$340
Endo Pharmaceuticals Inc.
$241
Dendreon Pharmaceuticals LLC
$226
PFIZER INC.
$209
Bayer HealthCare Pharmaceuticals Inc.
$199
AbbVie, Inc.
$186
NeoTract Inc.
$158
Medtronic USA, Inc.
$144
ABBVIE INC.
$122
Janssen Scientific Affairs, LLC
$120
Laborie Medical Technologies Corp.
$115
Ferring Pharmaceuticals Inc.
$101
Myovant Sciences Inc.
$100
Blue Earth Diagnostics Limited
$97
180 Medical, Inc.
$96
MEDIVATION FIELD SOLUTIONS LLC
$83
AbbVie Inc.
$73
Genentech USA, Inc.
$69
Avadel Specialty Pharmaceuticals, LLC
$65
Verity Pharmaceuticals Inc.
$58
BOSTON SCIENTIFIC CORPORATION
$57
Rochester Medical Corporation
$56
Teleflex LLC
$51
Amgen Inc.
$42
ABC Home Medical Supply, Inc.
$39
ROCHESTER MEDICAL CORPORATION
$26
Antares Pharma, Inc.
$25
Boston Scientific Corporation
$24
Progenics Pharmaceuticals, Inc.
$23
UROVANT SCIENCES INC
$23
ACCORD HEALTHCARE, INC.
$21
Myriad Genetic Laboratories, Inc.
$21
Olympus America Inc.
$21
EMD Serono, Inc.
$21
COLOPLAST CORP
$20
Hollister Incorporated
$18
Sun Pharmaceutical Industries Inc.
$18
Novum Pharma, LLC
$16
TOLMAR Pharmaceuticals, Inc.
$15
Retrophin, Inc.
$14
Axonics, Inc.
$14
Mission Pharmacal Company
$14
SRS Medical Systems, Inc.
$13
Allergan Inc.
$13
Allergan, Inc.
$13
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 28.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACTIVELIFE · AVEED · Alcortin A · Androgel · Axumin · BOTOX · BOTOX THERAPEUTIC · Bavencio · Bulkamid · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENTLECATH · INTERSTIM · LITHOVUE · LUPRON DEPOT · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PREMARIN · PROVENGE · PYLARIFY · Prolaris · Prolia · SPEEDICATH · SUTENT · SpeediCath · Trelstar · UROLIFT · UroCuff · UroLift · UroLift System · Urocit-K · VAPRO · VIAGRA · XGEVA · XIAFLEX · XTANDI · Xofigo · YONSA (abiraterone acetate) · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
234
Per 100K population
15.3
County median income
$128,329
Nearest hospital
SAGAMORE CHILDREN'S PSYCHIATRIC CENTER
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dourmashkin is a clinical cardiology specialist, with above-average Medicare volume (top 14% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dourmashkin experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Dourmashkin performed 1,378 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dourmashkin receive payments from pharmaceutical companies?
Yes. Dr. Dourmashkin received a total of $4,813 from 49 companies across 237 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dourmashkin's costs compare to other urology physicians in Melville?
Dr. Dourmashkin's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dourmashkin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Melville
Browse urology physicians in Melville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology